Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection.
Polymorphisms of interleukin-1 (IL-1) genes have been reported to modify the risk of gastric carcinoma (GC) in Caucasians. The significance of IL-1beta gene polymorphisms was evaluated in Japanese GC patients with or without infection of Helicobacter pylori and Epstein Barr virus (EBV) with special reference to the topographic features of GC. IL-1beta gene polymorphisms at positions -511 and +3953 were evaluated by PCR-RFLP and a penta-allelic polymorphism of IL-1RA by PCR in healthy controls (n = 103) and GC (n =140; corpus 95, antrum 45). EBV-infection was determined in the neoplastic tissues by EBER1 in situ hybridization, and H. pylori infection in nonneoplastic gastric mucosa by PCR targeting of the H. pylori urease A gene. GC consisted of EBV-associated (n = 24) and EBV-negative (n = 116) patients, whereas H. pylori infection was positive in 130 cases. Among IL-1beta gene polymorphisms, genotype IL-1beta+3953 C/T was more frequent in the EBV-negative (21%) and corpus GC (23%) patients, compared to the controls (10%), respectively, although there was no genotype IL-1beta+3953 T/T in either group. Thus, the effect of IL-1beta+3953 T was statistically significant in logistic regression models adjusted for age in EBV negativity (odds ratio [OR] 2.27, 95% confidence interval [CI] 1.02-5.05) and in the corpus GC (2.70, 1.19-6.12) with highest OR 3.55 (1.54-8.23) in EBV-negative corpus GC. There was no significant influence of IL-1 gene polymorphism in EBV-associated GC, but it occurred predominantly in the corpus (24/24) compared to EBV-negative GC (71/116) (p = 0.00002). There was no correlation between H. pylori infection and IL-1 gene polymorphism in GC. The cancer risk of the gastric corpus in Japanese is influenced by IL-1beta+3953 polymorphisms. On the other hand, the risk of EBV-associated GC, which occurs predominantly in the corpus, is not influenced by this pro-inflammatory polymorphism.
Sakuma
Kazuya
K
Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Uozaki
Hiroshi
H
Chong
Ja-Mun
JM
Hironaka
Mitsugu
M
Sudo
Makoto
M
Ushiku
Tetsuo
T
Nagai
Hideo
H
Fukayama
Masashi
M
D000368:Aged; D000483:Alleles; D045744:Cell Line, Tumor; D004247:DNA / Q000378:metabolism; D020031:Epstein-Barr Virus Infections / Q000150:complications; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism; D005787:Gene Frequency; D005838:Genotype; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori / Q000378:metabolism; D004854:Herpesvirus 4, Human / Q000378:metabolism*; D006801:Humans; D017403:In Situ Hybridization; D007249:Inflammation; D007375:Interleukin-1 / Q000235:genetics* / Q000378:metabolism; D007564:Japan; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D012367:RNA, Viral / Q000096:biosynthesis; D017472:Receptors, Interleukin-1 / Q000378:metabolism; D012306:Risk; D013274:Stomach Neoplasms / Q000235:genetics* / Q000382:microbiology* / Q000821:virology*
C099537:Epstein-Barr virus encoded RNA 1; D007375:Interleukin-1; D012367:RNA, Viral; D017472:Receptors, Interleukin-1; D004247:DNA